Medimaging Integrated Solution Inc. (6796) AI Stock Analysis

Medimaging Integrated Solution Inc.

(TWSE:6796)

Select Model

Rating:37Underperform

Price Target:TWD 46.00▼(-6.50% Downside)

Action:initiatedcoverage

Date:11/10/26

The overall score of 37 reflects a company in severe financial distress. The most significant factor is the extremely poor cash flow generation, with operations burning cash and free cash flow deeply negative, creating liquidity risk against a backdrop of surging debt. This is compounded by a collapse in profitability margins and a bearish technical trend with the stock in a sustained downtrend across all major moving averages. The excessively high P/E ratio on negligible earnings further confirms the stock's high-risk profile.

Positive Factors

Revenue AccelerationThe sharp 2025 revenue acceleration shows that the company can expand its top line after a period of stagnation. This stronger revenue base may support operating leverage and investment in imaging solutions, although future benefit depends on restoring profitability and cash conversion.

Negative Factors

Margin CompressionMaterial gross and net margin compression shows that recent sales growth has translated into limited earnings. With net margin near 1.2%, relatively small changes in costs or execution could materially affect profit, restricting internally funded investment and making earnings recovery less dependable.

Medimaging Integrated Solution Inc. (6796) vs. SPDR S&P 500 ETF (SPY)

Market Cap: TWD 1.95B
Dividend Yield: 0.51%
Average Volume (3M): 62.08K
Price to Earnings (P/E): 123.0
Beta (1Y): 0.36
Revenue Growth: 12.26%
EPS Growth: ―
Country: TW
Employees: 162
Sector: General
Sector Strength: 55
Industry: Medical - Devices

Medimaging Integrated Solution Inc. Business Overview & Revenue Model

Company Description

Medimaging Integrated Solution Inc. specializes in delivering advanced digital and mobile diagnostic technology. The company engineers and produces a variety of digital handheld diagnostic scopes, alongside their essential auxiliary equipment. A key...

Medimaging Integrated Solution Inc. Financial Statement Overview

Summary

Financial health is critically weak. The Income Statement (Score 35) shows collapsing margins and near break-even operations despite strong revenue growth. The Balance Sheet (Score 40) reflects a risky surge in leverage with a debt-to-equity ratio of 0.90 and a 1% return on equity. The Cash Flow Statement (Score 15) is the most alarming, with negative operating and free cash flow, indicating the core business is burning cash and cannot service its growing debt.

Income Statement

35Negative

Balance Sheet

40Negative

Cash Flow

15Very Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	682.01M	661.39M	538.92M	537.15M	502.09M	485.87M
Gross Profit	265.52M	276.55M	234.32M	307.76M	254.39M	255.72M
EBITDA	65.74M	74.50M	50.91M	119.38M	118.98M	114.93M
Net Income	14.32M	7.72M	5.61M	74.05M	70.02M	66.48M
Balance Sheet
Total Assets	1.65B	1.57B	1.36B	1.34B	841.41M	715.84M
Cash, Cash Equivalents and Short-Term Investments	617.44M	546.57M	380.18M	658.35M	335.11M	234.26M
Total Debt	453.18M	674.22M	443.15M	405.08M	87.67M	135.50M
Total Liabilities	801.99M	826.34M	613.67M	548.13M	193.26M	229.72M
Stockholders Equity	852.27M	745.37M	742.47M	792.50M	648.15M	486.12M
Cash Flow
Free Cash Flow	-73.24M	-53.26M	-175.90M	-30.91M	62.05M	15.13M
Operating Cash Flow	-40.51M	-16.16M	-50.40M	168.42M	112.79M	45.95M
Investing Cash Flow	-204.13M	-39.65M	7.73M	-328.68M	-102.63M	-19.82M
Financing Cash Flow	320.28M	219.85M	-57.06M	359.80M	40.36M	23.69M

Medimaging Integrated Solution Inc. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TW:6796 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TW:6527	73Outperform	TWD 1.86B	12.15	―	3.98%	-1.23%	10.20%
TW:3052	69Neutral	TWD 2.12B	9.38	―	5.71%	9.24%	-3.77%
TW:4138	68Neutral	TWD 2.15B	15.66	―	7.75%	-1.10%	-16.90%
TW:4116	62Neutral	TWD 1.82B	2.38	―	4.91%	3.85%	786.65%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
TW:6796	37Underperform	TWD 2.04B	123.00	―	0.51%	12.26%	―

* General Sector Average

Performance Comparison

TW:6796 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TW:6796	Medimaging Integrated Solution Inc.	49.20	-39.14	-44.31%
TW:3052	Apex Science & Engineering Corp.	10.50	-0.24	-2.23%
TW:4116	BenQ Medical Technology Corp.	40.70	-2.63	-6.06%
TW:4138	Dynamic Medical Technologies Inc.	54.20	-5.23	-8.80%
TW:6527	Crystalvue Medical Co Ltd	72.90	-5.53	-7.05%
TW:7881	Eyecare Tech, Inc.	73.20	-35.89	-32.90%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026

Medimaging Integrated Solution Inc. AI Stock Analysis